Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 1 von 31

Details

Autor(en) / Beteiligte
Titel
Triclosan inhibition of acute and chronic inflammatory gene pathways
Ist Teil von
  • Journal of clinical periodontology, 2010-05, Vol.37 (5), p.412-418
Ort / Verlag
Oxford, UK: Blackwell Publishing Ltd
Erscheinungsjahr
2010
Quelle
Wiley Online Library - AutoHoldings Journals
Beschreibungen/Notizen
  • Barros SP, Wirojchanasak S, Barrow DA, Panagakos F, Devizio W, Offenbacher S. Triclosan inhibition of acute and chronic inflammatory gene pathways. J Clin Periodontol 2010; 37: 412–418. doi: 10.1111/j.1600‐051X.2010.01548.x. Aim: We sought to determine whether triclosan (2,4,4′‐trichloro‐2′‐hydroxydiphenylether), an extensively used anti‐plaque agent with broad‐spectrum anti‐microbial activity, with reported anti‐inflammatory effects via inhibition of prostaglandin E2 and interleukin 1 (IL‐1)β, could also more broadly suppress multiple inflammatory gene pathways responsible for the pathogenesis of gingivitis and periodontitis. Materials and Methods: As an exploratory study, the effects of triclosan on the inflammatory gene expression profile were assessed ex vivo using peripheral whole blood samples from eight periodontally healthy donors. Ten‐millilitres whole blood aliquots were incubated 2 h with 0.3 μg/ml Escherichia coli lipopolysaccharide (LPS) with or without 0.5 μg/ml triclosan. Affymetrix microarray gene expression profiles from isolated leucocytes and pathway‐specific quantitative polymerase chain reaction arrays were used to investigate changes in expression of target cytokines and cell signalling molecules. Results: Ex vivo human whole blood assays indicated that triclosan significantly down‐regulated the LPS‐stimulated expression of Toll‐like receptor signalling molecules and other multiple inflammatory molecules including IL‐1 and IL‐6 and the dampening of signals that activate the T‐helper type 1 acquired immune response via suppression of CD70 with concomitant up‐regulation of growth factors related to bone morphogenetic protein (BMP)2 and BMP6 synthesis. Conclusions: Anti‐inflammatory effects were found in this exploratory survey, including suppression of microbial‐pathogen recognition pathway molecules and the suppression of acute and chronic mediators of inflammation.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX